Scheduling Nab-paclitaxel With Gemcitabine

Clinical trial NCT03529175 · COMPLETED

Trial details

NCT number: NCT03529175
Sponsor: CCTU- Cancer Theme
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic

Start date: 2014-01-01
Primary completion: 2016-06-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.